SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016389
Filing Date
2022-04-28
Accepted
2022-04-28 15:24:50
Documents
14
Period of Report
2022-06-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A eypt-def14a_20220623.htm DEF 14A 1322087
2 GRAPHIC gutl4fvrbzn2000011.jpg GRAPHIC 716
3 GRAPHIC gutl4fvrbzn2000007.jpg GRAPHIC 716
4 GRAPHIC gutl4fvrbzn2000008.jpg GRAPHIC 25517
5 GRAPHIC gutl4fvrbzn2000004.jpg GRAPHIC 716
6 GRAPHIC gutl4fvrbzn2000001.jpg GRAPHIC 5168
7 GRAPHIC gutl4fvrbzn2000003.jpg GRAPHIC 22211
8 GRAPHIC gutl4fvrbzn2000010.jpg GRAPHIC 51409
9 GRAPHIC gutl4fvrbzn2000002.jpg GRAPHIC 716
10 GRAPHIC gutl4fvrbzn2000005.jpg GRAPHIC 13343
11 GRAPHIC gutl4fvrbzn2000006.jpg GRAPHIC 49697
12 GRAPHIC gutl4fvrbzn2000009.jpg GRAPHIC 716
13 GRAPHIC gutl4fvrbzn2000013.jpg GRAPHIC 561685
14 GRAPHIC gutl4fvrbzn2000012.jpg GRAPHIC 790062
  Complete submission text file 0001564590-22-016389.txt   3422263
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Filer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-51122 | Film No.: 22865920
SIC: 3826 Laboratory Analytical Instruments
Industrial Applications and Services